What is the Market for Mass Spectrometry in Clinical Testing Application? According to Kalorama Information, the market for mass spectrometry is 1.5 billion dollars. While the lion's share of the market is research-based, a growing portion of the mass spectrometry industry is for clinical applications.
Mass spectrometry is a type of analysis that can determine what molecules make up a sample based on the spectrum created by the ions that are present.
Mass spectrometry has been primarily used in research applications, with early applications focused on small molecules. However, development of soft-ionization techniques such as matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) has made it possible to study larger molecules such as proteins, peptides, DNA, and other large molecules without extensive fragmentation, opening up a whole new world of opportunities as mass spectrometry now moves into the clinical laboratory.
Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.